Targeting T cell checkpoints and myeloid suppressor cells is effective in pancreatic cancer

被引：0
|
作者：
Gulhati, Pat [1 ]
DePinho, Ronald A. [2 ]
机构：
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NATURE CANCER | 2023年 / 4卷 / 01期
关键词：
D O I：
10.1038/s43018-022-00501-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Modulation of T cell immune checkpoints combined with inhibition of chemokine receptors on myeloid-derived suppressor cells can reprogram the highly suppressive tumor immune microenvironment of pancreatic ductal adenocarcinoma (PDAC), and generates durable complete responses in a PDAC mouse model. These results provide a testable clinical regimen for human PDAC.
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
  • [31] Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
    Pat Gulhati
    Aislyn Schalck
    Shan Jiang
    Xiaoying Shang
    Chang-Jiun Wu
    Pingping Hou
    Sharia Hernandez Ruiz
    Luisa Solis Soto
    Edwin Parra
    Haoqiang Ying
    Jincheng Han
    Prasenjit Dey
    Jun Li
    Pingna Deng
    Emi Sei
    Dean Y. Maeda
    John A. Zebala
    Denise J. Spring
    Michael Kim
    Huamin Wang
    Anirban Maitra
    Dirk Moore
    Karen Clise-Dwyer
    Y. Alan Wang
    Nicholas E. Navin
    Ronald A. DePinho
    Nature Cancer, 2023, 4 : 62 - 80
  • [32] THE EFFECT OF CONDITIONED MEDIA ON THE CELLULAR PROLIFERATION OF PANCREATIC CANCER CELLS, PANCREATIC STELLATE CELLS, AND MYELOID-DERIVED SUPPRESSOR CELLS
    Chong, Y. P.
    Samsudin, S.
    Bahrani, D. A.
    Chang, C. H.
    Masamune, A.
    Ng, S. H.
    Ismail, N.
    Ho, K. L.
    WORLD CANCER RESEARCH JOURNAL, 2025, 12
  • [33] Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
    Xin, Gang
    Chen, Yao
    Topchyan, Paytsar
    Kasmani, Moujtaba Y.
    Burns, Robert
    Volberding, Peter J.
    Wu, Xiaopeng
    Cohn, Alexandra
    Chen, Yiliang
    Lin, Chien-Wei
    Ho, Ping-Chih
    Silverstein, Roy
    Dwinell, Michael B.
    Cui, Weiguo
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (04) : 454 - 469
  • [34] Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
    He, Shuyan
    Zheng, Lu
    Qi, Chunjian
    MOLECULAR CANCER, 2025, 24 (01)
  • [35] Hampering Immune Suppressors Therapeutic Targeting of Myeloid-Derived Suppressor Cells in Cancer
    Albeituni, Sabrin Husein
    Ding, Chuanlin
    Yan, Jun
    CANCER JOURNAL, 2013, 19 (06): : 490 - 501
  • [36] The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients
    Tobin, Richard P.
    Davis, Dana
    Jordan, Kimberly R.
    McCarter, Martin D.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (02) : 381 - 391
  • [37] Potential Novel Ovarian Cancer Treatment Targeting Myeloid-Derived Suppressor Cells
    Abiko, Kaoru
    Hayashi, Takuma
    Yamaguchi, Ken
    Mandai, Masaki
    Konishi, Ikuo
    CANCER INVESTIGATION, 2021, 39 (04) : 310 - 314
  • [38] Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
    Ma, Jie
    Xu, Huaxi
    Wang, Shengjun
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [39] Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
    Thyagarajan, Anita
    Alshehri, Mamdouh Salman A.
    Miller, Kelly L. R.
    Sherwin, Catherine M.
    Travers, Jeffrey B.
    Sahu, Ravi P.
    CANCERS, 2019, 11 (11)
  • [40] Targeting NK-cell checkpoints for cancer immunotherapy
    Muntasell, Aura
    Ochoa, Maria C.
    Cordeiro, Luna
    Berraondo, Pedro
    Lopez-Diaz de Cerio, Ascension
    Cabo, Mariona
    Lopez-Botet, Miguel
    Melero, Ignacio
    CURRENT OPINION IN IMMUNOLOGY, 2017, 45 : 73 - 81
12345